J Korean Med Sci.  2024 Feb;39(6):e89. 10.3346/jkms.2024.39.e89.

Healthy Life Expectancy at Birth as the Target Indicator of National Health Strategy

• Jo MW

• KMID: 2553313
• DOI: http://doi.org/10.3346/jkms.2024.39.e89

Reference

1. World Health Organization. Healthy life expectancy (HALE) at birth. Accessed February 11, 2024. https://www.who.int/data/gho/indicator-metadata-registry/imr-details/66 .

2. Health Plan 2030. Accessed February 11, 2024. https://www.khepi.or.kr/board?menuId=MENU01289&siteId=null- .

3. Jung YS, Kim YE, Ock M, Yoon SJ. Trends in healthy life expectancy (HALE) and disparities by income and region in Korea (2008–2020): analysis of a nationwide claims database. J Korean Med Sci. 2024; 39(6):e46.

4. Oh J, Kim S, Lee M, Rhee SY, Kim MS, Shin JY, et al. National and regional trends in the prevalence of type 2 diabetes and associated risk factors among Korean adults, 2009-2021. Sci Rep. 2023; 13(1):16727. PMID: 37794087.

5. Rajaguru V, Kim TH, Shin J, Lee SG. Income disparities in cancer screening: a cross-sectional study of the Korean National Health and Nutrition Examination Survey, 2013–2019. Front Public Health. 2022; 10:820643. PMID: 35372248.

6. Yoon SJ, Go DS, Park H, Jo MW, Oh IH, Kim YE. The Korean national burden of disease study: from evidence to policy. J Korean Med Sci. 2018; 34(Suppl 1):e89. PMID: 30923492.